GL 047064
Latest Information Update: 11 May 2004
At a glance
- Originator Genelabs Technologies
- Class Antivirals
- Mechanism of Action RNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Viral infections